The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...

The deal hands AbbVie a drug that’s shown early promise in multiple myeloma and may be useful treating other cancers and ...

Although 40 states have legalized medical marijuana, the federal government still lists it as a controlled substance.

The federal judge reignited the legal standoff over President Trump’s efforts to deny citizenship to children born to ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...

The biotech will add a pivotal Phase III cohort to its ongoing Phase I/II trial evaluating ATSN-201 in X-linked retinoschisis ...

A growing disconnect remains between what generics are approved and what are actually accessible, GoodRx said.

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...

The FDA published more than 200 letters that it sent to companies when it rejected their medicines, but the letters came with a caveat.

The FDA on Thursday said it published more than 200 decision letters, known as complete response letters, that it issued in response to applications for approval of drugs or biological products ...